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Abstract  
Objective: To determine the relationship of obesity indicators with certain hemodynamic and metabolic cardiovascular risk factors, at the initial diagnosis 
of hypertension in a random population, in search of a treatable cause 
Methods: A case control study was conducted on 201 subjects aged between 25-60 years, diagnosed  primarily as prehypertensive or  hypertensive stage I 
and II , selected from five general practitioners clinics in Karachi. Estimated of hematocrit, hemoglobin, triglycerides, low density lipoproteins, serum 
potassium level and aldosterone was done. Their body mass index and waist hip ratio were calculated by measuring body weight, height, waist and hip 
circumference. The values obtained were compared with 75 controls with normal blood pressure. 
The mean and standard deviation were computed. Analysis was done by SPSS version 15.LSD test was applied to compare pair-wise group. Pearson’s 
correlation was applied to find out association of different variables with one another, within each of the four groups 
Results: The overall percentages of overweight and obese subjects were higher in all four groups. The mean hematocrit and hemoglobin levels were 
highest in HTN stage –I (44.7±5.25 and15.4±2.20 respectively). Hemoglobin was strongly correlated to systolic blood pressure and waist hip ratio in both 
hypertension stages-I and II (p<0.01). Whereas hematocrit was positively correlated to body mass index, triglycerides, serum potassium and aldosterone 
levels in both stages of hypertension (p<0.01) 
Conclusion: High hematocrit, hemoglobin, triglyceride levels, visceral fat accumulation and aldosterone secretion are important and independent risk 
factors for hypertension.  
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Introduction 
Hematocrit (Hct) or packed cell volume represents the 
cellular portion of blood mainly red blood cells, 
expressed as percentage (% vol/vol) and is the major 
determinant of whole blood viscosity (WBV). 1 Other 
factors that contribute to blood viscosity in addition to 
Hct include plasma proteins, plasma lipids and other 
rheological factors. 2 It has long been known after 
Poiseuille-Hagen equation, that a strong association 
exists between WBV and hypertension (HTN), as 
hyperviscosity affects peripheral resistance (PR), and 
thus blood pressure (BP), not only by increasing 
resistance to flow and workload on heart, but also by 
hindering vasodilation. 3  
Hct above the normal range along with related 
hematological variables such as hemoglobin (Hb), red 
blood cell count and mean corpuscular volume, 
predispose to both arterial and venous thrombosis, in 
primary and secondary erythropoiesis 4 and may be a 
responsible factor in causing cerebral ischemia, 
especially if associated with inflammation.5 Hb the 
oxygen carrying pigment in the blood, is an important 
nitric oxide (NO) buffer and a modulator of its 
bioavailability and hence plays a central role in vascular 
function. 
 Population-based studies have consistently demonstrated 
that on average Hb is raised in patients with essential 
HTN; thus it is suggested that Hb-dependent mechanism 
contributes to endothelial dysfunction in HTN by 
influencing availability of NO. 6  Hb, by a series of 
biochemical processes including NO oxidation and 
nitrosylation of iron molecules and sulfur containing 
amino acids in globin molecules, neutralizes the NO very 
effectively. This direct negative effect on NO availability 
might explain the link between high Hct and 
cardiovascular disease (CVD).7 A study revealed that Hb 
level > 17 g/dL is associated with coronary artery disease 
(CAD). 8 
Several epidemiological studies supported the evidence 
that elevated blood viscosity and Hb concentration are 
related to HTN, insulin resistance (IR) 9, metabolic 
syndrome, severe obesity and peripheral atherosclerosis 
in adults 10. A study showed that low density lipoprotein 
cholesterol (LDL) is the principal lipid that 
independently influences the WBV 11, whereas other 
studies suggested that high triglyceride (TG) and low 
HDL levels are responsible for elevating WBV and 
promoting atherosclerosis. 12, 13 WBV is inversely related 
to flow and may predispose to IR and type 2 diabetes 
mellitus, by limiting delivery of glucose, insulin and 
oxygen to metabolically active tissues 14 
Prospective studies have revealed that intraperitoneal and 
posterior subcutaneous fat mass is strongly linked with 
dyslipidemia and IR 15. Moreover free fatty acids released 
from visceral adipose tissues have been shown to 
increase IR and aldosterone production.16 Plasma renin 
and aldosterone levels both, have been reported to be 
three folds greater with secondary erythrocytosis 
compared to controls. 17 
Epidemiologists and biologists have been trying to 
identify new risk factors, particularly modifiable risk 
factors that could explain some of the variability in HTN 
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and CVD, not explained by traditional risk factors. Thus 
over hundred risk factors have been proposed by 
Framingham Heart Study. This study focuses on finding 
an association and correlation between hemodynamic 
factors Hct and Hb, plasma lipids concentration (TG, 
LDL), body fat composition, reflected by Body mass 
index (BMI), Waist hip ratio (WHR) and aldosterone 
hormone. 
Subjects and Methods  
It was a case control study with purposive sampling, 
carried out on 276 subjects, aged between 25-60 years, 
selected from five general practitioners clinics in Karachi 
and were categorized into four groups according to 7th 
JNC report. 18 The control group (A) had normal systolic 
(SBP) and Diastolic BP (DBP). The prehypertension 
(pre-HTN) group (B) had systolic BP between 120-140 
mmHg and diastolic BP >80 and < 90 mmHg, 
hypertension stage-I (C) with SBP >140 and <160 
mmHg; DBP >90 and <100 mmHg and Stage-II (D) with 
SBP >160 and DBP >100 mmHg.   
Patients suffering from any other disease (cardiac, renal, 
hepatic etc) other than HTN were excluded from study 
(exclusion criteria). 
 BP measurement: both systolic and diastolic BP were 
measured twice by mercury sphygmomanometer half an 
hour apart and then averaged.  
Anthropometric measurements: height and weight 
were measured and BMI and WHR were calculated by 
formulae. BMI= Weight in Kg/ height in cm2   WHR= 
waist in cm/height in cm 
Measurement of Hematocrit: traditionally it is 
determined by measuring the height of red cell column in 
microhematocrit tube following centrifugation. 
Automated analyzer (Advia) calculates the Hct by 
multiplying the red cell count and the mean red cell 
volume, both of which are measured directly by machine. 
Normal value: 38-42% 
Estimation of hemoglobin: is done traditionally using 
the cyanomethemoglobin method. To measure the Hb 
concentration, a lysing agent is added to a sample of 
diluted blood, which disrupts all red cells in the sample 
and released Hb, which is then converted into 
Cyanomethemoglobin and the concentration is read by 
spectrophotometer with the wavelength set at peak 
absorbance of cyanomethemoglobin. The concentration 
of Hb is then calculated from the optical density of the 
solution. Hb concentration is 1/3rd of Hct and is reported 
as grams/dL of blood. Normal values: 12-15 g/dL 
Quantitative Determinations of TG and LDL were 
performed by enzymatic in vitro test in human serum on 
Roche cilinical chemistry analyzer using commercially 
avaialbale GPO-PAP and LDL kit respectively 
 
Values NCEP19 TG mg/dL LDL mg/dL 
Normal <150 <100  
Borderline: >150-199 130-159 
High: >200-499 > 160       
                                                                             
      
Measurement of Aldosterone: was done by 125Ι 
radioimmunoassay, based on aldosterone specific 
antibody immobilized to the wall of polypropylene tube 
(ELISA) 
Normal value: Standing: 4-31 ng/dL, Recumbent: 1-16 
ng/dL   
Ethical consideration: Written consents of subjects 
were taken and study was approved by Board of 
advanced studies of Karachi University. 
Results  
The mean Hct level of HTN stage-I was significantly 
higher (p<0.05) than the mean of HTN stage-II 
(44.7±5.25 vs 42.0±3.83; p=0.014) as well as control and 
pre-HTN groups, as shown in Table 1. Hct level showed 
significant positive correlations with BMI, TG, K+ and 
aldosterone, in both stages-I and II of HTN (Table 2) 
The mean Hb value was significantly higher in HTN 
stage-I (15.4±2.20) as compared to control, pre-HTN 
group (p<0.001), and HTN stage-II group i.e. 13.2±1.56 
(p<0.005) as shown in Table 3. Significant correlation 
was seen between Hb level and systolic BP only in HTN 
stage-I, whereas no positive relation was observed with 
diastolic BP. Hb was positively correlated to systolic BP 
and WHR in both HTN stages -I and II (Table 2). 
The serum TG level was on higher side in HTN stage-I 
(161.8±79.9) and II (166.6±66.7) as compared to control 
and pre-HTN groups. The mean LDL level was 
106.5±30.7, 105.6±32.7, 116.4±32.9, and 103.7±29.2 in 
four groups respectively, the highest level being in HTN 
stage-I (Table 4). 
The values of serum K+ were insignificant among four 
groups: 4.5±0.43, 4.47±0.42, 4.26±0.51 and 4.41±0.45 
respectively. The mean aldosterone level was on higher 
normal side in HTN stages-I and II, i.e. 12.41±5.72, and 
2.05±6.84 (Table 4). 
Statistical analysis: Data was analyzed by SPSS version 
15. The variables were presented as Mean ± standard 
deviation. Analysis of variance was performed to 
compare four study groups and LSD test was applied to 
compare pair-wise group. 
Test of  linear correlation was applied to asses 
relationship of different variable with systolic and 
diastolic pressure. Coefficient correlations of parameters 
were carried out with each other and within each of the 
four groups to identify the association of different 
variables with one another in different stages of 
hypertension. P value is taken as significant at <0.05. 
Discussion  
One of the objectives of evaluation of patients with 
documented HTN is to reveal identifiable causes of high 
BP. 
The purpose of this study was to explore the association 
of some of the environmental and endogenous risk 
factors and to identify their correlation in different stages 
of HTN in Pakistani population, whose 18% adults suffer 
from this disease.20 The BP level attributed to HTN in 
most of the studies done in Pakistan was >140/90 mmHg, 
but in this study subjects were classified into three groups 
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of HTN including the pre-HTN stage with high normal BP.
Table 1: Comparison of mean Hematocrit (Hct) among study groups (n=276) 
S # A B C D 
Group Control Pre HTN HTN stage-I HTN stage-II 
 (n = 75) (n = 55) (n = 70) (n = 76) 
Mean± SD 40.3 ± 4.30 40.4 ± 3.50 44.7 ± 5.25 42.0 ± 3.83 
- v/s A=0.929 v/s A=0.001* v/s A=0.381 





- v/s D=0.474 - - 
 
* The mean difference is significant at the 0.05 level. 
 
Table 2: Coefficient correlation of HCT and Hb with other variables in HTN stage-I and II 
 
Variable SBP BMI WHR TG Serum K+ Aldosterone 
Hemoglobin       
HTN stage-I .396** .077 .246** .012 .116 .134 
HTN Stage-II .450** .072 .236** .073 .171 .052 
Hematocrit       
HTN stage-I .097 .298** .220 .362** .266* .615** 
HTN stage-II .082 .263** .247* .340** .294** .533** 
 
** Significant at the 0.01 level (2-tailed) 
*  Significant at the 0.05 level (2-tailed) 
 
Table 3: Comparison of mean Hemoglobin (Hb) among study groups (n = 276) 
S # A B C D 
Group Control Pre HTN HTN stage-I HTN stage-II 
 (n = 75) (n = 55) (n = 70) (n = 76) 
Mean± SD 12.3 ± 1.84 12.7 ± 1.97 15.4 ± 2.20 13.2 ± 1.56 
- v/s A=0.352 v/s A<0.001* v/s A=0.004* 





- v/s D=0.08 - - 
 
* The mean difference is significant at the 0.05 level. 
 
Table 4: comparison of mean of different variables among study groups (Mean±SD) 
 
Group Control Pre-HTN HTN Stage-I HTN stage-II 
BMI 24.9±3.77 26.4±4.47 28.4±4.53* 26.6±5.33 
WHR 0.90±0.06 0.94±0.07 0.99±0.05* 0.99±0.06 
TG 134.6±60.3 136.1±62.2 161.8±79.9* 166.6±66.7 
LDL 106.5±30.7 105.6±32.7 116.4±32.9* 103.7±29.2* 
Serum K+ 4.5±0.43 4.47±0.42 4.26±0.51 4.41±0.45 
Aldosterone 9.17±3.49 8.76±3.31 12.41±5.72* 12.05±6.85 




Most of the participants were educated and belonged to 
lower middle class; detail of subject profile has been 
published previously. 21  
Hct and HTN are intricately correlated, such that 
lowering the Hct can directly decrease BP by altering 
total peripheral resistance. Blood viscosity can therefore 
be employed as a very useful and sensitive indicator of 
BP. 22 The mean Hct level of HTN stage-I was 
significantly higher than the mean of all other groups; 
whereas the mean Hb level was also significantly higher 
in HTN stage-I (15.4±2.2) as compared to control and 
pre-HTN groups (p<0.001) and HTN stage-II group 
(p<0.05). Significant correlation was seen between Hb 
level and systolic BP both in HTN stage-I and II.  
The quantity and distribution of body fat was assessed by 
two indicators, BMI and WHR in this study, as WHR is 
regarded as three times better predictor of risk of heart 
attack as compared to BMI.23  This study confirmed that 
percentage of overweight and obese persons, has risen 
sharply in Pakistani general population even in middle 
and lower classes. In this study 69 % subjects in control 
group, 80% in pre-HTN, 90% in stage-I and 76 % in 
stage-II were overweight and obese, which is contrary to 
previously reported data showing 25% overweight and 
10.3% obese people in our population. 24  
Both Hct and Hb were positively correlated to BMI in 
HTN stage-II, and to WHR in HTN stage-I and II. This 
suggests a link between these hematologic parameters 
and obesity, as strongly claimed by a latest study that 
among classical cardiovascular risk factors, WHR is 
closely related to blood viscosity. 25 Another study 
supported our finding in which untreated hypertensive 
patients had higher BMI, Hct and BP in both sexes. 26  A 
study on Iranian women reported that obese women have 
greater iron stores in terms of serum ferritin, Hb and Hct 
concentration than do non-obese women and are more 
prone to develop HTN. 27 
A correlation between Hb and IR was found in non-
smokers in a study which also showed association of Hb 
with other components of IR such as BMI, WHR, lipid 
profiles, and systolic BP, which is consistent with our 
findings.28 Our results thus provide support for a 
relationship between IR and hematological parameters 
such as Hb and Hct. Previously a study revealed that high 
erythrocyte count and Hb are associated with obesity and 
HTN 9 and another study documented that with treatment 
of anemia, increased Hct was followed by increased 
blood viscosity together with a rise of BP. 29 
Hyperviscosity has been found to be related to not only 
HTN but also IR, metabolic syndrome, severe obesity 
and peripheral atherosclerosis in adults.10 The importance 
of TG as an independent risk factor has been reported by 
several studies, as TG rich lipoproteins penetrate 
endothelial cell layer, forming foal cells, a hallmark of 
atherosclerosis, the process especially enhanced in low 
shear stress areas of arteries.30 IR and hyperinsulinemia 
have been observed in over 70% of non-obese, non-
diabetic subjects with essential HTN, suggesting the 
resistance results from endothelial dysfunction and 
impaired endothelial dependent vasodilation.31 A study 
confirmed that insulin was related to BMI and 
aldosterone in both normotensive and hypertensive 
subjects. 32 This study reported significant correlation of 
Hct with hormone aldosterone in both HTN stage-I and II 
for the first time. 
The interrelationship among these factors as evident by 
this study, may tentatively suggest the possible sequence 
of mechanisms causing HTN as: visceral fat 
accumulation (TG, LDL) in upper abdomen impairs 
endothelial function, leading to a decrease in 
responsiveness of cells to insulin (IR) as well as decrease 
K+ entry into the cells, increasing plasma K+ level, 
which is a very strong stimulus for secretion of 
aldosterone, and needs to increase only 1 meq/L to 
stimulate its release from adrenal cortex. The aldosterone 
in turn, causes sodium and water retention. High Hct 
further aggravates the condition by increasing peripheral 
resistance and Hb impairs vasodilation by affecting NO 
availability; thus all these factors cumulatively result in 
HTN  
Conclusion 
Patients with a new diagnosis of HTN should be 
evaluated with a history, physical examination and the 
initial workup which should include the simple and cost 
effective tests, that provide an insight to the possible 
treatable causes of high BP and assessment for the 
presence of target organ damage. To promote primary 
prevention of HTN, identification and monitoring of 
increase in weight, lipid profile, blood glucose level and 
other related factors in HTN-prone subjects are 
considered important to prevent Clustering of different 
risk factors. 
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